Parameters | 28-day survivors | 28-day nonsurvivors | p |
---|---|---|---|
T1 (within 12 h after ECMO placement) | (n = 24) | (n = 24) | |
ECMO blood flow (L/min) | 2.3 (0.8) | 2.5 (0.6) | 0.191 |
TSVD (mm/mm2) | 22.5 (2.7) | 22.0 (3.5) | 0.576 |
HI | 0.30 (0.1–0.44) | 0.38 (0.09–0.71) | 0.909 |
T2 (24 h after ECMO placement) | (n = 22) | (n = 21) | |
ECMO blood flow (L/min) | 2.2 (0.4) | 2.5 (0.5) | 0.022 |
TSVD (mm/mm2) | 22.8 (3.6) | 22.8 (3.4) | 0.994 |
HI | 0.21 (0–0.41) | 0.24 (0.18–0.57) | 0.269 |
T3 (48 h after ECMO placement) | (n = 19) | (n = 15) | |
ECMO blood flow (L/min) | 2.1 (0.4) | 2.5 (0.9) | 0.176 |
TSVD (mm/mm2) | 21.7 (4.4) | 22.7 (3.4) | 0.442 |
HI | 0.2 (0.07–0.3) | 0.33 (0.14–0.44) | 0.040 |
T4 (72 h after ECMO placement) | (n = 17) | (n = 11) | |
ECMO blood flow (L/min) | 2.2 (0.4) | 2.8 (1.2) | 0.097 |
TSVD (mm/mm2) | 23.8 (3.4) | 21.8 (4.5) | 0.177 |
HI | 0.14 (0.05–0.25) | 0.18 (0.05–0.32) | 0.353 |
T5 (96 h after ECMO placement) | (n = 17) | (n = 9) | |
ECMO blood flow (L/min) | 2.1 (0.6) | 3.0 (1.4) | 0.089 |
TSVD (mm/mm2) | 23.3 (2.9) | 21.3 (4.8) | 0.183 |
HI | 0.31 (0.1–0.54) | 0.18 (0–0.56) | 0.458 |